| Characteristic | Percentage of respondents |
|---|---|
| Limiting how much drug companies can increase the price for prescription drugs each year to no more than the rate of inflation | 61% |
| Capping out-of-pocket costs for insulin at $35 a month | 59% |
| Placing a limit on out-of-pocket health care costs for seniors, such as co-pays for prescription drugs | 52% |
| Allowing the federal government to negotiate with drug companies to get a lower price on prescription drugs for people with Medicare | 48% |
| Expanding government health insurance coverage for lower-income people in states that have not expanded their Medicaid program | 42% |
| Increasing government funding for access to mental health services and training for mental health providers | 42% |
| Taking federal action to improve the safety and quality of care in nursing homes | 40% |
| Providing more funding to continue the COVID-19 pandemic response | 25% |
| Making permanent the additional financial help from the COVID-19 relief bill for people who buy their own insurance | 21% |
* For commercial use only
Basic Account
Starter Account
Professional Account
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
Key health indicators
Disease burden
Expenditure
Public health programs
Hospitals and diagnostics
Health insurance
Further related statistics
* For commercial use only
Basic Account
Starter Account
Professional Account
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
